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Introduction
Random-pattern tissue flaps are frequently used in plastic and reconstructive surgery to cover soft tissue defects that may have been caused due to trauma or tumor-resection. Necrosis of the ischemic portion of the random-pattern skin flap is one of the common complications observed during these tissue transfer procedures. This unexpected tissue loss could result in significant cosmetic and functional defects [1] . The reason for such necrosis could either be due to loss or limited blood supply to the tissue flaps and the underlying molecular mechanisms of this process remain to be defined. Thus, many approaches, such as using unspecific local or systemic physical stressors, pharmacological agents, or even treating the flap with different growth factors, have been explored to reduce distal flap necrosis. However, most of these techniques require invasive and expensive administration of these substances. Therefore, novel approaches are needed to prevent such skin tissue necrosis and improve the success of the plastic and reconstructive surgical procedure.
Towards this end, our research focuses on a transcription factor, hypoxia inducible factor 1 (HIF-1). Its role in cellular response to ischemia has been extensively investigated in numerous studies. HIF-1 is composed of two basic helix-loop-helix proteins subunits, α and β. HIF-1α, plays an essential role in triggering cellular protection and metabolic alterations in response to oxygen deprivation [2, 3] . Angiogenesis is an important factor for the survival of random-pattern skin flap [4] . HIF-1α is known to regulate angiogenesis and microcirculation through mediators, such as vascular endothelial growth factor (VEGF) [5] and heme oxygenase (HO)-1 [6] . Thus, indicating the role of HIF-1α expression in the survival of random-pattern skin flaps. Recently, several studies have confirmed this role by demonstrating that intraperitoneal treatment with a HIF-1α stabilizer dimethyloxalylglycine (DMOG) or deferoxamine (DFO), significantly increased HIF-1α expression and enhanced skin flap survival [7] [8] [9] [10] .
Isoflurane, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane, is halogenated ether used for clinical inhalational anesthesia. We and others have demonstrated that isoflurane was able to modulate expression of several genes related to cell survival, including HIF-1α [11] [12] [13] [14] [15] . Tissue preconditioning properties of isoflurane have been well described in the literature and are established in clinical practice [14, [16] [17] [18] [19] . Therefore, we hypothesized that isoflurane preconditioning might be beneficial in reducing necrosis in ischemic skin flaps through up-regulation of HIF-1α and its downstream genes.
In this study, we performed in vitro and in vivo experiments to test whether isoflurane preconditioning could induce tolerance against hypoxia/ischemia in skin flap tissues. In addition, we also elucidated the underlying molecular events to confirm the role of HIF-1α in this process.
Materials and Methods

Cell lines and animals
Human umbilical vein endothelial cells (HUVECs) and human skin fibroblast cells were purchased from the Cell Bank of Shanghai Institute for Biological Science (Shanghai, China). These cell lines were seeded at 1×10 3 per cm 2 on tissue culture plates. Twenty-four hours later, non-adherent cells were washed off using phosphate buffered saline (PBS). The adherent cells were grown to confluency. Cells from passages 3 or 4 were used in the following experiments.
Adult male Sprague-Dawley rats (weighing 300 ± 20 g) were obtained from SLAC National Rodent Laboratory Animal Resource (Shanghai, China). Rats were housed in temperature-and humidity-controlled, specific pathogen-free (SPF) conditions on a 12 h light/12 h dark cycle with free access to food and water. Animal study was in accordance with the National Institutes of Guide for Care and Use of Laboratory Animals (NIH US publication 86-23, revised 1985) and approved by the Committee of Animal Experimental Ethical Inspection Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine.
Isoflurane exposure
Cells were incubated in vitro with isoflurane (Abbott Laboratories, Abbott Park, IL) for 4 h in a gastight chamber inside the culture incubator as described previously [20, 21] . Isoflurane concentrations used in vitro assays were 0.16, 0.32 and 0.48 mM, equivalent to 0.5, 1.0 and 1.5 minimum alveolar concentrations (MAC), respectively. Animals were exposed to isoflurane as described previously [18] . Briefly, a homemade tilt transparent plastic chamber with in-and out-flow at the opposite long ends was used. Rats were exposed to 1.5% isoflurane (equivalent to 1.0 MAC for rats) balanced with air through an isoflurane vaporizer for 4 h period of time, while the control animals were exposed to the same gas without isoflurane. Gas sample was taken from a hole adjacent to the outlet for measurement. Concentrations of isoflurane and O 2 were monitored by Datex infrared analyzer (Capnomac, Helsinki, Finland). The concentration of isoflurane inhalation used in this study was a common clinical concentration that did not cause any cardiorespiratory compromise in our pilot studies.
To determine whether isoflurane exposure activates HIF-1α in HUVECs and human skin fibroblast cells, we exposed these cells to 0.32 mM isoflurane for 4 h and then harvested them for qRT-PCR, ELISA, and western blot analysis for HIF-1α, VEGF, and HO-1 expression at different time points up to 24 h. Untreated cells and those exposed to 1.0 mM DMOG (Cayman Chemicals, Ann Arbor, MI) for 4 h served as negative or positive controls respectively. To explore the effect of isoflurane preconditioning on hypoxic conditions, HUVECs were divided into CON (normoxia), Hypoxia (hypoxia for 4h), ISO (0.32 mM isoflurane exposure for 4 h + normoxia condition for 24 h), and ISO plus Hypoxia (0.32 mM isoflurane exposure for 4 h + normoxia condition for 24 h + hypoxia for 4h) groups. Hypoxic condition was made by continuous supplement of humidified 95% N 2 /5% CO 2 in a tightly closed chamber. These cells were then collected to assess the expression of HIF-1α.
To further elucidate the signaling pathways that mediate the effects of isoflurane preconditioning on HIF-1α expression, we incubated HUVECs with or without the phosphatidylinositol 3-kinase (PI3K) inhibitors LY 294002 at 50 µM or wortmannin at 5 µM, and mammalian target of rapamycin (mTOR) inhibitor rapamycin at 5µM and glycogen synthase kinase 3β (GSK 3β) inhibitor SB 216763 at 10 µM for 30 min prior to 0.32 mM isoflurane exposure for 4 h. These inhibitors were all purchased from Cell Signaling Technology (Danvers, MA). Twenty-four hours later, the cells were harvested for western blot analysis for total or phospho-Akt (Ser 473), total or phospho-mTOR (Ser 2448), total or phospho-GSK 3β (Ser 9) and HIF-1α expressions. The downstream molecules of mTOR, phosphorylation of 4E-BP1 (Ser 65) and P70 s6k (Thr 389) [22] , were also investigated. Furthermore, to clarify if the HIF-1α protein stability is regulated by isoflurane pre-treatment, protein half-life study was performed as described previously [23, 24] . HUVECs were cultured in 1.0 mM DMOG, 5 ng/ml TGF-β1, 0.32 mM isoflurane or normoxia condition for 4 h. The DMOG, TGF-β1 and normoxia condition served as positive or negative controls, respectively. Following exposure, 5 µM cycloheximide (CHX) (Sigma, St. Louis, MO) was added to cell cultures for different periods of time ranging from 15 to 45 min. The relative HIF-1α protein level at time zero was defined as 100%. To determine whether isoflurane exposure inhibited PHD2 expression, we performed a western blot analysis of PHD2 protein in HUVECs.
Finally, to evaluate the effect of isoflurane preconditioning on skin tissue flap survival and the potential role of HIF-1α, we randomly divided 40 rats into five groups (8 rats per group). Group 1 rats were subjected to a standard random-pattern skin flap surgery without any treatments served as the negative control (CON); Group 2, 3, and 4 animals were administrated with PBS, scrambled siRNA or HIF-1α siRNA respectively for 48 h and exposed to isoflurane preconditioning followed by the random-pattern skin flap surgery (ISO, Neg-siR, and HIF-siR); Group 5 rats received DMOG treatment, served as a positive control (DMOG). These animals received intraperitoneal administration of DMOG at a dosage of 40 mg/kg body weight 48 h before the surgical procedure, at the time of the surgery and 24 h after surgery [8] . Rats were anesthetized for skin flap survival, full-field laser perfusion imager (FLPI) measurements (at 7 day postoperatively) and for microvessel density evaluation (at 10 day post-operation). To generate the lentivirus, the recombinant vector and packaged plasmids (psPAX2 and pMD) were co-transfected into 293 T cells. The final titer of recombinant virus was 1 × 10 9 TU/ml. The lentivirus were injected into the subdermal layer spanning the whole area of the mapped skin flap for 48 h prior to the onset of experimental procedures (a total of 12 injection points on the flap, 50 µl each point, total 600µl).
Preparation of random-pattern skin flaps
After an overnight fast, animals were first anesthetized by an intraperitoneal injection of 40-50 mg/kg sodium pentobarbital. Adequate anesthesia depth was confirmed by pinch flexion/withdrawal test. Under aseptic conditions, a random-pattern, caudally based dorsal skin flap (2.5 × 10 cm) was elevated from the rats and resutured after a silicon sheet was placed between the flap and wound bed. No axial vessels were incorporated into the flap in which the ischemic gradient is proportional to the distance from the base.
Flap survival evaluation
The skin flap survival was evaluated by a digital image analysis. The necrotic area (defined by dark color and scar formation) and total flap areas were delineated and surface areas were calculated using Image-Pro Plus Software (version 6.0, Media Cybernetics Inc., Bethesda, MD) by an investigator who was blinded to the experimental groups. The skin flap survival results were expressed as percentages of the survival area relative to the total surface area of the flap.
Full-field laser perfusion imager (FLPI)
FLPI were measured under anesthesia using The Moor instrument (Axminster, UK) as described previously [25] . Briefly, the FLPI measurements were performed in a warm and quiet environment. The CCD camera was placed 30 cm above the back of each rat. Settings for low-resolution/high-speed images included a display rate of 25 Hz, time constant of 1.0 s, and camera exposure time of 20 ms, with values expressed in blood perfusion unit (BPU). The contrast images were processed to display a color-coded live flux image (red: high perfusion, blue: low perfusion).
Enzyme-Linked Immunosorbent Assay (ELISA)
VEGF levels were measured using Quantikine human enzyme-linked immunosorbent assay (ELISA) kits from R&D Systems (Minneapolis, MN) by strictly adhering to the manufacturer's instructions. Levels of VEGF protein in cell culture supernatants were expressed in pg/ml.
Real-time RT-PCR
Total RNA was isolated from cells or skin flap tissues using the Trizol reagent (Invitrogen, Carlsbad, CA) and RNeasy kit (Qiagen, Düsseldorf, Germany). These RNA samples were then reverse transcribed into single-stranded cDNA by using the first-strand cDNA synthesis kit (Promega, Madison, WI). These cDNA products were further amplified using qPCR by SYBR Green RT-PCR kit (Bioteke, Beijing, China). Sequencespecific primers are listed in Table 1 . The PCR cycles were as follows: 95 °C for 3 min and then 39 cycles of 95 °C for 10 s, 55 °C for 1 min, 72 °C for 45 s and a final 65°C for 5 min. Relative expression of qPCR products was determined by the Delta-Delta CT method to normalize with GAPDH mRNA expression.
Protein extraction and Western blot
Total cellular protein was extracted from rat tissues or cultured cells by using a RIPA lysis buffer (Beyotime, Jiangsu, China) containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 1 mg/ml leupeptin, 2.5 mM sodium orthovanadate and 1 mg/ ml aprotinin. Western blot analysis was then performed as described previously [11, 12] . Briefly, 30-80 μg of protein samples were loaded onto a 10% SDS gel, and after electrophoresis, were transferred onto nitrocellulose membranes. The primary antibodies against HIF-1α (Novus Biologicals, Littleton, CO), VEGF (Abcam, Cambridge, UK), HO-1 (Abcam), and PHD2 (Novus Biologicals) were used. The primary antibodies against total and phospho-Akt (Ser 473), total and phospho-mTOR (Ser 2448), total and phospho-GSK3β (Ser 9), total and phospho-4E-BP1 (Ser 65), total and phospho-P70 s6k (Thr 389) were purchased from Cell Signaling Technology. Immunoreactivity signal was visualized by Tanon gel imaging systems (Shanghai, China) and analyzed by Image-Pro Plus Software. 
Evaluation of microvessel density in tissue samples
To evaluate microvessel density, we first stained tissue samples with the endothelial cell marker von Willebrand Factor [25, 26] . In brief, rats were anesthetized and full thickness skin flap specimens measuring 0.5 cm × 0.5 cm from proximal margin 3 cm from the base were harvested, fixed in 10% saline-buffered formalin, embedded in paraffin, and cut into 5-µm-thick sections. We then stained these sections with a rat monoclonal anti-von Willebrand Factor antibody (DAKO, Denmark). Microvessel density was assessed by measuring the number of von Willebrand Factor-positive microvessels in 5 fields of each immunohistochemistry slide (×100). All evaluation of microvessel density was conducted by two investigators who were blinded to the identification of tissue groups.
Statistical analysis
Data are expressed as mean ± SD. One-way analysis of variance (ANOVA) followed by post hoc Newman-Keuls Multiple Comparison Test was used for statistical analysis. Data were analyzed using Prism 5 for Windows software (GraphPad Software, Inc, San Diego, CA). A p value less than 0.05 was considered statistically significant.
Results
Isoflurane exposure induced expression of HIF-1α, VEGF and HO-1 in vitro
In this study, we first exposed HUVECs to isoflurane for modification of different gene expressions. Our data showed that the levels of HIF-1α protein exhibited a marked increase 4 h after isoflurane treatment (0.34 ± 0.02 vs. 0.18 ± 0.01, p < 0.05) and increased further at 12 h and 24 h (0.89 ± 0.09, 0.92 ± 0.11 vs. 0.18 ± 0.01, p < 0.01) compared to the control cells (Fig.1A) . Moreover, the expression of HO-1 and VEGF proteins was also induced by approximately 3 fold (0.78 ± 0.09 vs. 0.26 ± 0.01, p < 0.01) and 2.5 fold (507 ± 19 vs. 196 ± 19, p < 0.01), respectively, 24 h after isoflurane exposure compared to the control cells (Fig.1A  & F) . The mRNA levels of these two genes were also similar following isoflurane exposure (Fig.1D) . Similar observations were also made in human skin fibroblast cells (Fig.1, B, E & F) .
HIF-1α expression was analysed using western blot in HUVECs 24 h after preconditioning with 0.16, 0.32 and 0.48 mM isoflurane for 4 h. Our data showed that both 0.32 and 0.48 mM isoflurane treatment induced the HUVECs to express HIF-1α protein compared to 0.16 mM group (0.42 ± 0.06, 0.47 ± 0.08 vs. 0.26 ± 0.04, p < 0.05). However, there was no significant difference between 0.32 and 0.48 mM groups (Fig.1C) . Thus, the concentration of 0.32 mM (1.0 MAC) was used in the following experiments. To understand the impact of isoflurane preconditioning against hypoxic injury, we determined the effects of isoflurane preconditioning on expression of HIF-1α in hypoxic condition. The data shows that incubation of HUVECs in the hypoxia condition or isoflurane alone for 4 h induced the levels of HIF-1α protein significantly and that a further accumulation was noted in ISO plus Hypoxia group (Fig. 1G) . 
Isoflurane activates Akt-mTOR and Akt-GSK 3β pathway to increase HIF-1α expression
To determine the underlying molecular events by which isoflurane induced HIF-1α expression, we studied the Akt-mTOR and Akt-GSK 3β pathway. We found that HUVECs A further accumulation was noted in isoflurane plus hypoxia. *P < 0.05 and **P < 0.01 compared to the CON or to 0.16 mM isoflurane exposure.
Fig. 2. Isoflurane exposure activated
Akt-mTOR and Akt-GSK 3β pathway and increased HIF-1α expression. (A) Cultured HUVECs were pre-treated with LY 294002 or wortmannin and then exposed to isoflurane. Western blot analysis shows that both LY 294002 and wortmannin inhibited isoflurane-induced increases in p-Akt (Ser 473), p-mTOR (Ser 2448), p-GSK 3β (Ser 9) and HIF-1α. (B) Cultured HUVECs were pre-treated with SB 216763 and then exposed to isoflurane. Western blot analysis shows that SB 216763 pre-treatment could further increase isoflurane-induced p-GSK 3β (Ser 9) and HIF-1α expression compared to the isoflurane-alone cells. (C, D) Cultured HUVECs were pretreated with wortmannin or rapamycin then exposed to isoflurane. Western blot analysis shows that both wortmannin and rapamycin inhibited isoflurane-induced p-4E-BP1 (Ser 65) and p-P70 s6k (Thr 389) and HIF-1α expression.
exposed to isoflurane-induced expression of phospho-Akt (Ser 473), phospho-mTOR (Ser 2448) and phospho-GSK 3β (Ser 9) (Fig. 2A) . In addition to the blockade of activation of Akt, mTOR and GSK 3β proteins, LY 294002 and wortmannin significantly inhibited isofluraneinduced expression of HIF-1α protein ( Fig. 2A) . Likewise, rapamycin, an inhibitor of mTOR kinase activity, attenuated the induction of 4E-BP1 and P70 s6k phosphorylation and HIF-1α expression induced by isoflurane treatment (Fig. 2C & D) . On the other hand, expression of phospho-GSK 3β (Ser 9) and HIF-1α proteins induced by isoflurane exposure could be enhanced further by SB 216763 (Fig.2B ). These data demonstrates that both Akt-mTOR and Akt-GSK3β signaling pathways were involved in HIF-1α activation induced by isoflurane exposure.
Isoflurane increased HIF-1α protein stability
A recent study showed non-hypoxic stimulation [such as transforming growth factor β1 (TGF-1β)] was able to stabilize HIF-1α protein [23, 24] . Therefore, we assessed whether isoflurane can induce HIF-1α protein stability. Our data showed that the half-life of HIF-1α protein was up to 15 min in TGF-1β-stimulated cells and up to 12 min in isofluranetreated cells after addition of CHX to block on-going protein synthesis; however, normoxic control cells showed only ~5 min of HIF-1α protein (Fig. 3A, C &D) . In addition, exposure to 
The effect of HIF-1α knockdown on regulating expression of HIF-1α and its downstream genes in vivo
The effect of HIF-1α knockdown on regulating expression of HIF-1α and its downstream genes in vivo was investigated. Our data exhibited intracellular green fluorescence in skin flap specimens from the animals, 48 h after GFP-labeled siRNA-related lentivirus subdermal layer injection, whereas no such fluorescence was found in the skin flaps of PBS-injected control animals (Fig.4A ). The rats with and without HIF-1α knockdown were treated with 1.5% isoflurane for 4 h. Twenty-four hours later, dorsal skin flap specimens were harvested for qRT-PCR and western blot analysis. The knockdown efficiency of HIF-1α siRNA was confirmed by a significant decrease in the expression of HIF-1α and its target gene, VEGF (Fig.4B & C) . In addition, qRT-PCR data showed that isoflurane preconditioning in PBS and Neg-siR groups didn't significantly change expression of HIF-1α mRNA (Fig.4B) , indicating that isoflurane preconditioning modulates HIF-1α via a posttranscriptional pathway, similar to the findings from our previous study [11, 12] .
HIF-1α knockdown abrogated isoflurane preconditioning-improved skin flap survival
As regularly observed, necrosis was seen consistently in the distal region of the flap from all animal experiments. In this study, we took digital photographs on postoperative day 7 and found that the characteristic distribution of necrosis and the visible differences between the each group (Fig.5A) . Quantitative data showed a higher survival rate of the tissue flaps in the ISO, Neg-siR and DMOG group compared to the negative control rats (56.7 ± 6.7%, 55.2 ± 6.5% 62.5 ± 6.0% vs. 48.5 ± 5.6%, p < 0.05 or p < 0.01). However, knockdown In HIF-siR group, the HIF-1α mRNA levels decreased significantly. Expression of VEGF mRNA was induced by isoflurane preconditioning but blocked by HIF-1α siRNA transfection compared to PBS or scrambled siRNA plus isoflurane-treated animals. (C) Tissues from skin flap were subjected to western blot. Expression of HIF-1α and VEGF protein was induced by isoflurane preconditioning but blocked by HIF-1α siRNA transfection compared with PBS or scrambled siRNA plus isoflurane-treated animals. A, Ten days after operation, the tissue flaps were stained with anti-von Willebrand Factor antibody and microvessel density was evaluated under a microscope (red arrows) (×100) and summarized. B, Statistical analysis of microvesssel counts in different groups. Enhanced vascularization existed in the ISO, the Neg-siR and the DMOG group (n = 6, *p < 0.05 compared with CON. #p < 0.05 compared with ISO).
At 10 days after operation, we found that isoflurane and DMOG treatment tended to result in a significant increase in microvessel count compared to CON group (14.5 ± 4.3, 15.8 ± 3.6 vs. 8.5 ± 2.1, p < 0.05). Knockdown of HIF-1α expression also attenuated isoflurane preconditioning induced improvement of vascularity (8.8 ±3.5 vs. 14.5 ± 4.3, p < 0.05) (Fig. 6A & B) .
Discussion
In this study, we investigated the effects of isoflurane in improving the survival of random-pattern skin flaps in rat and the molecular mechanisms underlying this process.
Results from the present study confirmed our hypothesis that isoflurane preconditioning protects skin flap against ischemic necrosis in a rat model. The major findings were: 1). Isoflurane preconditioning improved survival of the random-pattern skin flap in rat model; 2). Under normoxic conditions, isoflurane preconditioning with clinically relevant doses induces expression of HIF-1α protein and subsequently VEGF and HO-1 expression; and 3). Isoflurane-induced HIF-1α expression was mediated by activation of the Akt-mTOR and Akt-GSK 3β signaling pathways. Further studies are necessary to evaluate the clinical significance of isoflurane-improved survival of the random-pattern skin flap.
Previous studies, including ours, have confirmed that isoflurane treatment was able to induce expression of HIF-1α in neurons [12] , myocardium [13] , renal [14] , and protected these organs from ischemic injury. Thus, in this study, we extend the previous findings by showing a similar protective effect in the skin flap tissues. Vascular endothelial cells are the lining component for all vascular networks, and are sensitive to ischemia [27, 28] . HUVECs are regarded as a standard endothelial cell line for analysis of vasoreactive responses to various conditions [8, 28] . In addition, skin fibroblasts comprise a large percentage of the cellular portion of the skin [29] . To confirm the human relevance of the findings, HUVECs and human skin fibroblast cells were chosen as the representative cell lines for in vitro study.
Our in vitro data clearly demonstrated that isoflurane treatment induced HIF-1α expression. Most importantly, our in vivo study showed that isoflurane preconditioning significantly increased HIF-1α levels in rat skin flap tissues and reduced ischemia-induced skin flap necrosis. However, this protective effect was attenuated by knockdown of HIF-1α expression using HIF-1α siRNA, suggesting that isoflurane-protective effect is regulated by HIF-1α.
Moreover, the defined molecular mechanisms by which isoflurane induces HIF-1α is not fully understood. Levels of HIF-1α protein are determined by the balance between protein synthesis and degradation [30] . In line with a previous study [13] , our data confirmed that activation of the Akt-mTOR pathway played a role in isoflurane-induced HIF-1α expression and mTOR activated P70 s6K and 4E-BP1 [22] to control the translation of HIF-1α mRNA. In addition, GSK 3β is another downstream substrate of Akt and may promote HIF-1α stabilization and expression [31, 32] . These data led us to studying the role of Akt-GSK 3β in the regulation of HIF-1α protein after isoflurane treatment. Our in vitro data also showed that treatment of HUVECs with isoflurane increased the levels of phospho-Akt and GSK 3β and therefore induced HIF-1α expression. Such an induction of HIF-1α and phospho-GSK 3β expression could be blocked by LY 294002 and wortmannin. In addition, inhibiting GSK 3β activity with SB 216763 could further increase isoflurane-induced phospho-GSK 3β and HIF-1α expression compared to the isoflurane-alone cells. These data clearly suggest that isoflurane-induced HIF-1α expression was also mediated or at least in part by activation of the Akt-GSK 3β gene pathway. Activated Akt will phosphorylate GSK 3β protein and decrease GSK 3β kinase activity and in turn increases HIF-1α levels. In comparison of the half-life of HIF-1α protein in the cells stimulated by isoflurane and normoxic control, the data showed that isoflurane significantly increased HIF-1α protein stability. Under normoxia condition, PHD2 is the critical oxygen sensor controlling the low steady-state levels of HIF-1α [33] and decreased PHD2 activity could result in HIF-1α stabilization. In this study, however, exposure to isoflurane did not inhibit PHD2 expression, suggesting that isoflurane-induced HIF-1α stabilization was independent to PHD. It is likely that GSK 3β negatively regulated HIF-1α by initiating HIF-1α phosphorylation and promoting proteasomal degradation [32] , although further study is needed to clarify it.
HO is a ubiquitous enzyme that catalyses the breakdown of heme to equimolar amount of biliverdin, carbon monoxide and ferrous iron. Among the three mammalian isoforms of HO, only the HO-1 is inducible. Activation of HO-1 has been shown to minimize the damage after ischemia followed by reperfusion in a number of organ systems including the skin flap tissues [6, 18, 34, 35] . VEGF is one of the most important growth factors involved in vasculogenesis and angiogenesis. Acute hypoxia will induce expression of HO-1 and VEGF, which is transcriptionally mediated by HIF-1α activation [15, 36] . On this basis, these two HIF-1α target genes can modulate microcirculatory properties and can therefore play a role to induce the survival of random-pattern skin flaps. Using anti-von Willebrand factor staining to visualize microvessels in tissues, we observed the number of von Willebrand Factor positive microvessels was higher in the ISO group compared with CON group, suggesting that increased expression by isoflurane preconditioning cooperates with hypoxic stabilization and accumulation of HIF-1α which ensures enhanced expression of the HIF-1α target genes, such as HO-1 and VEGF, and up-regulates vascularity.
Our current study also has some potential limitations. For example, HIF-1α is a powerful transcription factor with hundreds of down-stream genes. In this study, we just demonstrated induction of VEGF and HO-1 expression. Other genes may also have participated in isoflurane-induced survival of the random-pattern skin flap, e.g., isoflurane preconditioning was able to induce erythropoietin (EPO) expression [14] , which is also capable to prevent musculocutaneous tissue from ischemic necrosis [37] . In addition, bone marrow-derived cells including hematopoietic stem cells, mesenchymal stem cells, endothelial progenitor cells and their generations improve wound healing by mobilization, differentiation and angiogenesis [38] [39] [40] . These processes require the local environment to generate appropriate chemotactic signals and progenitor cells to respond appropriately through signaling pathways such as stromal cell derived factor-1 (SDF-1)-CXCR4 [41] and VEGF-VEGF receptor 2 [39] . Chang et al. confirmed that DFO promoted ischemic flap survival through increased endothelial progenitor cells mobilization via increased HIF-1α and SDF-1α levels, which could be reversed by age-related HIF-1α down regulation [9] . Recently, Takaku et al. demonstrated that DMOG activated the HIF-1α not only in ischemic area but also in bone marrow cells, thereby enhanced the recruitment of progenitor cells from bone marrow to the ischemic part of flap to reconstitute the vasculature [7] . From these points of view, bone marrow-derived cells may play an essential role in promoting ischemic skin flap survival. While the question of whether isoflurane preconditioning can induce bone marrow-derived progenitor cells mobilization, differentiation and homing should be tested in future in vivo experiments. Even though isoflurane preconditioning may not be superior to DMOG administration, our current data may still have significant clinical perspectives. This is due to the fact that isoflurane is a safe inhalation anaesthetic and has been widely used in plastic and reconstructive surgery for many years. Isoflurane preconditioning is non-invasive, easily applicable and cost-effective. Thus, we expect that it will be of clinical significance to use isoflurane for surgical procedures with the random-pattern skin flaps.
In summary, our study provides evidence that isoflurane preconditioning at a clinically relevant concentration, 24 h before ischemic assault can improve survival of the random-pattern skin flaps. This protective effect seems to be mediated through increase in expression of HIF-1α protein, perhaps via Akt-mTOR and Akt-GSK3β signaling pathways. In our previous study [12] , we showed that induction of HIF-1α was due to extracellular signal-related kinases (ERK), while in the current manuscript, we found Akt-GSK 3β and AktmTOR in mediating HIF-1α induction, indicating that it is multiple factorial regulations of HIF-1α expression. Moreover, both Akt and ERK genes are part of the RAS signaling pathway. However, in our future study, we will perform experiments to investigate which gene(s) is most important in isoflurane regulation of HIF-1α expression in skin flap tissues.
